No interventions need to be specified for this study

OTHER4 trials

Sponsors

Ruijin Hospital

Conditions

Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaCohortDiffuse Large B Cell LymphomaExtranodal LymphomaIntravascular Large B-Cell LymphomaLymphomaLymphoma, B-Cell

Unknown Phase

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Ruijin HospitalAnaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Diffuse Large B Cell Lymphoma +6

Start: 2023-07-01End: 2024-10-01Target: 10000Updated: 2023-06-18

A Retrospective Study on Extranodal DLBCL

CompletedNCT06549361

Ruijin HospitalDiffuse Large B Cell Lymphoma, Extranodal Lymphoma, Lymphoma

Start: 2022-05-01End: 2023-09-01Updated: 2024-08-12

A Real-World Study on Extranodal Lymphoma

Not yet recruitingNCT06573099

Ruijin HospitalDiffuse Large B Cell Lymphoma, Extranodal Lymphoma, Lymphoma +2

Start: 2024-09-01End: 2029-09-01Target: 5000Updated: 2024-08-27

Shanghai Lymphoma Clinical Cohort

Not yet recruitingNCT07285174

Ruijin HospitalCohort, Lymphoma

Start: 2025-12-18End: 2029-12-31Target: 1000Updated: 2025-12-16